186 related articles for article (PubMed ID: 16710909)
21. Management of cancer of the head and neck--a cocktail with your PORT?
Saunders MI; Rojas AM
N Engl J Med; 2004 May; 350(19):1997-9. PubMed ID: 15128901
[No Abstract] [Full Text] [Related]
22. Cetuximab in the treatment of head and neck cancer.
Bernier J
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1539-52. PubMed ID: 17134359
[TBL] [Abstract][Full Text] [Related]
23. Are anti-vitamin K drugs contraindicated with cetuximab during head-and-neck cancer concomitant radiotherapy?
Brohée D; Henry AR; Castadot P
Acta Clin Belg; 2013; 68(3):237-9. PubMed ID: 24156231
[TBL] [Abstract][Full Text] [Related]
24. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
Kies MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
[TBL] [Abstract][Full Text] [Related]
25. [Three cases of head and neck cancer made resectable by hyperthermo-chemo-radiotherapy].
Fujimura T; Yonemura Y; Kamata T; Takegawa S; Sugiyama K; Nishimura G; Miyata R; Yamaguchi A; Miyazaki I; Nakajima K
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1322-7. PubMed ID: 3430022
[No Abstract] [Full Text] [Related]
26. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.
Chan AK; Sanghera P; Choo BA; McConkey C; Mehanna H; Parmar S; Pracy P; Glaholm J; Hartley A
Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):34-9. PubMed ID: 20863676
[TBL] [Abstract][Full Text] [Related]
27. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
Pfister DG; Su YB; Kraus DH; Wolden SL; Lis E; Aliff TB; Zahalsky AJ; Lake S; Needle MN; Shaha AR; Shah JP; Zelefsky MJ
J Clin Oncol; 2006 Mar; 24(7):1072-8. PubMed ID: 16505426
[TBL] [Abstract][Full Text] [Related]
28. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.
Duprez F; Bonte K; De Neve W; Boterberg T; De Gersem W; Madani I
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):450-8. PubMed ID: 20381266
[TBL] [Abstract][Full Text] [Related]
29. Cetuximab in squamous cell head and neck carcinomas.
Gebbia V; Giuliani F; Valori VM; Agueli R; Colucci G; Maiello E
Ann Oncol; 2007 Jun; 18 Suppl 6():vi5-7. PubMed ID: 17591832
[TBL] [Abstract][Full Text] [Related]
30. Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis.
Birnbaum A; Dipetrillo T; Rathore R; Anderson E; Wanebo H; Puthwala Y; Joyce D; Safran H; Henderson D; Kennedy T; Ready N; Sio TT
Am J Clin Oncol; 2010 Apr; 33(2):144-7. PubMed ID: 19786848
[TBL] [Abstract][Full Text] [Related]
31. [Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases].
Xia LP; Zhang B; Liu MZ; Hu PL; Chen XX; Guo GF; Qiu HJ; Rong YM; Qian SY; Zhou FF; Huang YY; Wang TL
Ai Zheng; 2009 Sep; 28(9):977-82. PubMed ID: 19728918
[TBL] [Abstract][Full Text] [Related]
32. Treatment for head and neck cancer.
FDA Consum; 2006; 40(3):7. PubMed ID: 16909488
[No Abstract] [Full Text] [Related]
33. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck.
Kim S; Eleff M; Nicolaou N
Head Neck; 2011 Feb; 33(2):286-8. PubMed ID: 19953623
[TBL] [Abstract][Full Text] [Related]
34. The emerging role of cetuximab in head and neck cancer: a 2007 perspective.
Panikkar RP; Astsaturov I; Langer CJ
Cancer Invest; 2008 Feb; 26(1):96-103. PubMed ID: 18181051
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy plus chemotherapy for head and neck cancer.
Michalski J; Emami B
N Engl J Med; 1993 Feb; 328(8):580. PubMed ID: 8426629
[No Abstract] [Full Text] [Related]
36. Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
Conley BA; Gore-Langton RE; Cheson BD
Oncology (Williston Park); 2000 Apr; 14(4):553-4, 559, 561. PubMed ID: 10826315
[No Abstract] [Full Text] [Related]
37. Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck.
Bernier J
Nat Clin Pract Oncol; 2008 Dec; 5(12):705-13. PubMed ID: 18825142
[TBL] [Abstract][Full Text] [Related]
38. Cetuximab-induced pneumonitis in head and neck cancer patient.
De Vos FY; Driessen CM; Jaspers HC; van Herpen CM; Simons B
Oral Oncol; 2012 Jun; 48(6):e17-8. PubMed ID: 22342570
[No Abstract] [Full Text] [Related]
39. Integrating novel agents into the curative treatment of head and neck cancer.
Haddad R; Allen A; Wirth L; Tishler R; Posner M
Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
[No Abstract] [Full Text] [Related]
40. Radiotherapy plus chemotherapy for head and neck cancer.
Mendenhall WM; Parsons JT
N Engl J Med; 1993 Feb; 328(8):579-80. PubMed ID: 8489586
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]